NCT02598596 — "Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect" trial site landscape

Public-registry site landscape for NCT02598596, “Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect”, a Gout study sponsored by Ampel BioSolutions, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT02598596 (registry record)
Study title	Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
Sponsor	Ampel BioSolutions, LLC
Condition(s)	Gout
Phase	PHASE2
Listed sites	11
Intervention(s)	Pegloticase, Azathioprine
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT02598596.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT02598596 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Gout trials

← Eichor home · All tracked trials · Gout studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →